Cellulitis Unknown Status Phase 3 Trials for Moxifloxacin (DB00218)

Also known as: Cellulitis, unspecified

IndicationStatusPhase
DBCOND0014773 (Cellulitis)Unknown Status3
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00323219Oral Moxifloxacin Versus Cefazolin and Oral Probenecid in the Management of Skin and Soft Tissue Infections in the Emergency DepartmentTreatment